Investigadors
-
Anna Planas Ballvé
Neuropsiquiatria i neuropsicologia clíniques
-
Asunción Ávila
Neuropsiquiatria i neuropsicologia clíniques
Phd -
Dolors Lozano
Neuropsiquiatria i neuropsicologia clíniques
-
Ester Moral Torres
Neuropsiquiatria i neuropsicologia clíniques
-
Irati Zubizarreta
Neuropsiquiatria i neuropsicologia clíniques
Phd -
Joan Bello López
Neuropsiquiatria i neuropsicologia clíniques
Phd -
José Vicente Hervas-garcía
Neuropsiquiatria i neuropsicologia clíniques
Phd -
Juan Bernardo Gómez
Neuropsiquiatria i neuropsicologia clíniques
-
Juan José Mengual
Neuropsiquiatria i neuropsicologia clíniques
-
Laura Gubieras Lillo
Neuropsiquiatria i neuropsicologia clíniques
-
Mª Isabel Gómez Ruiz
Neuropsiquiatria i neuropsicologia clíniques
Phd -
Marta Balagué
Neuropsiquiatria i neuropsicologia clíniques
-
Mercè Lleixà
Neuropsiquiatria i neuropsicologia clíniques
-
Mireia Grau
Neuropsiquiatria i neuropsicologia clíniques
-
Mónica Prat
Neuropsiquiatria i neuropsicologia clíniques
-
Montse Vacas Moreira
Neuropsiquiatria i neuropsicologia clíniques
-
Nuria Caballol
Neuropsiquiatria i neuropsicologia clíniques
-
Pablo Millet Balanzó
Neuropsiquiatria i neuropsicologia clíniques
-
Sonia María García
Neuropsiquiatria i neuropsicologia clíniques
-
Xavier Cardona
Neuropsiquiatria i neuropsicologia clíniques
Contacteu amb el grup
Formulari-
Calabria M, Hernández M, Cattaneo G, Suades A, Serra M, Juncadella M, Rene R, Sala I, Lleo A, Ortiz-Gil J, Ugas L, Ávila A, Gómez-Ruiz I, Ávila C, Costa A. 196/20
Active bilingualism delays the onset of mild cognitive impairment.
Neuropsychologia. 2020 Sep;146:107528.
-
Crespo-Cuevas AM, Canento T, Hernández-Pérez M, Cáceres C, González A, Ispierto L, Mataro M, Vilas D, Planas-Ballvé A, Martín L, Muñoz-Ortiz L, Arenillas JF, Via M. Castanon M, Millan M, Dorado L, López-Cancio E. 316/20
The Barcelona-Asymptomatic Intracranial Atherosclerosis (AsIA) study: Subclinical cervico-cerebral stenosis and middle cerebral artery pulsatility index as predictors of long-term incident cognitive impairment.
Atherosclerosis. 2020 Nov;312:104-109
-
Santos García D, López Ariztegui N, Cubo E, Vinagre Aragón A, García-Ramos R, Borrué C, Fernández-Pajarín G, Caballol N, Cabo I, Barrios-López JM, Hernández Vara J, Ávila Rivera MA, Gasca-Salas C, Escalante S, Manrique de Lara P, Pérez Noguera R, Álvarez Sauco M, Sierra M, Monje MHG, Sánchez Ferro A, Novo Ponte S, Alonso-Frech F, Macías-García D, Legarda I, Rojo A, Álvarez Fernández I, Buongiorno MT, Pastor P, García Ruíz P. 214/20
Clinical utility of a personalized and long-term monitoring device for Parkinson's disease in a real clinical practice setting: An expert opinion survey on STAT-ON™.
Neurologia. 2020 Dec 24;S0213-4853(20)30339-X.
-
Santos-Garcia D, de Deus Fonticoba T, Suarez Castro E, Aneiros Diaz A, Cores Bartolome C, Feal Panceiras M J, Paz Gonzalez J M, Valdés Aymerich L, Garcia Moreno J M, Blázquez Estrada M, Jesús S, Mir P, Aguilar M, Planellas LL, Garcia Caldentey J, Caballol N, Legarda I, Cabo López I, Lopez Manzanares L, Ávila Rivera MA, Catalán M J, López Diaz LM, Borrue C, Álvarez Sauco M, Vela L, Cubo E, Martinez Castrillo JC, Sanchez Alonso P, Alonso Losada M G, López Ariztegui N, Gaston I, Pascual-Sedano B, Seijo M, Ruiz Martinez J, Valero C, Kurtis M, González Ardura J, Prieto Jurczynska C, Martinez-Martin P. 292/20
Quality of life and non-motor symptoms in Parkinson's disease patients with subthreshold depression.
J Neurol Sci. 2020 Aug 28;418:117109
-
Santos-García D, de Deus Fonticoba T, Suárez Castro E, Aneiros Díaz A, McAfee D, Catalán MJ, Alonso-Frech F, Villanueva C, Jesús S, Mir P, Aguilar M, Pastor P, García Caldentey J, Esltelrich Peyret E, Planellas LL, Martí MJ, Caballol N, Hernández Vara J, Martí Andrés G, Cabo I, Ávila Rivera MA, López Manzanares L, Redondo N, Martinez-Martin P; COPPADIS Study Group, McAfee D. 272/20
Non-motor symptom burden is strongly correlated to motor complications in patients with Parkinson's disease.
Eur J Neurol. 2020 Jul;27(7):1210-1223.
-
Santos-García D, De Deus FT, Cores BC, Valdés AL, Suárez CE, Aneiros Á, Jesús S, Aguilar M, Pastor P, Planellas L, Cosgaya M, García CJ, Caballol N, Legarda I, Hernández VJ, Cabo I, López ML, González AI, Ávila MA, José CM, Nogueira V, Puente V, García MJM, Borrué C, Solano VB, Álvarez SM, Vela L, Escalante S, Cubo E, Carrillo PF, Martínez CJC, Sánchez AP, Alonso LMG, López AN, Gastón I, Kulisevsky J, Blázquez EM, Seijo M, Rúiz MJ, Valero C, Kurtis M, de Fábregues-Boixar O, González AJ, Prieto JC, López DL, McAfee D, Mir P; COPPADIS Study Group. 267/20
Mood in Parkinson's disease: From early- to late-stage disease.
Int J Geriatr Psychiatry. 2020 Nov 10.
-
Santos-García D, de Deus-Fonticoba T, Suárez Castro E, M Aneiros Díaz Á, Feal-Painceiras MJ, Paz-González JM, García-Sancho C, Jesús S, Mir P, Planellas L, García-Caldentey J, Caballol N, Legarda I, Hernández-Vara J, González-Aramburu I, Ávila-Rivera MA, Catalán MJ, Nogueira V, Álvarez-Sauco M, Vela L, Escalante S, Cubo E, Sánchez-Alonso P, Alonso-Losada MG, López-Ariztegui N, Martinez-Martin P; COPPADIS Study Group. 319/20
The impact of freezing of gait on functional dependency in Parkinson's disease with regard to motor phenotype.
Neurol Sci. 2020 Oct;41(10):2883-2892.
-
Santos-García D, Suárez Castro E, de Deus Fonticoba T, Feal Panceiras MJ, Muñoz Enriquez JG, Paz González JM, Cores Bartolomé C, Planellas LL, García Caldentey J, Caballol N, Legarda I, Cabo López I, López Manzanares L, Ávila Rivera MA, Catalán MJ, Nogueira V, Borrué C, Álvarez Sauco M, Vela L, Cubo E, Martínez Castrillo JC, Sánchez Alonso P, Alonso Losada MG, López Ariztegui N, Gastón MI, Kulisevsky J, Pagonabarraga J, Seijo M, Ruíz Martínez J, Valero C, Kurtis M, González Ardura J, Prieto C, Mir P, Martinez-Martin P. 310/20
Sleep Problems Are Related to a Worse Quality of Life and a Greater Non-Motor Symptoms Burden in Parkinson's Disease.
J Geriatr Psychiatry Neurol. 2020 Oct 12;891988720964250
-
Ávila A, Caballol N, Martín-Baranera M, Gómez-Ruiz I, Balagué-Marmaña M, Planas-Ballvé A, Cardona X. 142/19
Rasagiline and safinamide as a dopamine sparing therapy for Parkinson's disease.
Acta Neurol Scand. 2019;140(1):23-31.
-
Gómez-Choco M, Mengual JJ, Rodríguez-Antigüedad J, Paré-Curell M, Purroy F, Palomeras E, Fuentes B, Ustrell X, Tembl J, Rodríguez-Yañez M, Castellanos M, Martí-Fabregas J, Serena J. 101/19
Pre-Existing Cerebral Small Vessel Disease Limits Early Recovery in Patients with Acute Lacunar Infarct.
J Stroke Cerebrovasc Dis. 2019;28(11):104312.
Projectes
-
- Any 2020
- HSDMB
Evaluación de la percepción de las personas con esclerosis múltiple avanzada sobre sus necesidades sociosanitarias y calidad de vida: un estudio epidemiológico observacional transversal exploratorio.
-
PROMOTOR:
Esclerosis Múltiple España
-
TIPUS E:
EPA-OD
- Any 2020
- HSDMB
Estudio observacional, transversal, no-intervencionista y multicéntrico para la caracterización de la marcha en pacientes con Esclerosis Múltiple Remitente-Recurrente y Esclerosis Múltiple Secundaria Progresiva medida por el sistema de sensor integrado en plantilla FeetMe®. MS-FEET Pro,
-
PROMOTOR:
Novartis Farmaceutica S.A.
-
TIPUS E:
PS
- Any 2020
- HSDMB
Estudio prospectivo para evaluar la evolución clínica e inmunológica de pacientes con esclerosis múltiple en tratamiento modificador de la enfermedad infectados versus no infectados por SARS-COV-2.
-
PROMOTOR:
Dr. Luis Brieva Ruiz del Hospital Arnau de Vilanova de Lleida
-
TIPUS E:
EPA-AS
- Any 2020
- HSDMB
A 2-year follow-up study to assess cognition and health-related quality of life in participants with highly-active relapsing multiple sclerosis, having participated in the CLARIFY MS trial.
-
PROMOTOR:
Merck Healthcare KGaA, Darmstadt
-
TIPUS E:
RD2015
- Any 2020
- HSDMB
Terapia de células dendríticas combinada con tratamiento inmunomodulador en el tratamiento de la esclerosis múltiple.
-
PROMOTOR:
IDIBAPS (Institut d'Investigació Biomèdica August Pi i Sunyer)
-
TIPUS E:
RD2015
- Any 2020
- HSDMB
The Prevalence and Burden of Headaches Disorders in the Children and Adolescents of Catalonia.
-
PROMOTOR:
Dr. Juan Bernardo Gómez Galván
-
TIPUS E:
PI
- Any 2020
- HSDMB
Randomised, double-blind, placebo-controlled, clinical study to evaluate the effect of opicapone 50 mg on Parkinson’s disease patients with motor fluctuations and associated pain.
-
PROMOTOR:
Bial - Portela & Ca, S.A.
-
TIPUS E:
RD2015
- Any 2020
- HSDMB
Evaluation of the perception of people with advanced multiple sclerosis on their socio-health needs and quality of life: an exploratory cross-sectional observational epidemiological study.
-
PROMOTOR:
Multiple Sclerosis Spain
-
TIPUS E:
EPA-OD
- Any 2020
- HSDMB
A 2-year follow-up study to assess cognition and health-related quality of life in participants with highly-active relapsing multiple sclerosis, having participated in the CLARIFY MS trial.
-
PROMOTOR:
Merck Healthcare KGaA, Darmstadt
-
TIPUS E:
RD2015
Línies d’actuació- Parkinson’s disease in our area
- Psychiatric pathology in neurological diseases
- Bilingualism in dementia, stroke and movement disorders
- Multiple Sclerosis: treatment and quality of life
- Cognitive and fluid biomarkers in neurodegenerative disorders
Documents
Informació d’interès
Enllaços
